Enhancement of IgE-mediated histamine release from human basophils by immune-specific lymphokines
- PMID: 6160007
- PMCID: PMC1537015
Enhancement of IgE-mediated histamine release from human basophils by immune-specific lymphokines
Abstract
Human leucocytes (basophils) release histamine when exposed to ragweed antigen E or anti-IgE. The present study shows that when leucocytes from BCG-positive donors are first incubated with PPD and then challenged with anti-IgE, histamine release is enhanced. In contrast, when leucocytes from BCG-negative donors are incubated with PPD and then challenged with anti-IgE there is no enhancement of histamine release. The enhancement of histamine release was detected within 24 hr after addition of PPD, but was maximal at 48 to 72 hr. Supernatant fluids collected from these leucocyte cultures revealed the presence of a soluble mediator(s) which, when incubated with leucocytes from BCG-negative donors, enhanced the release of histamine. Examination of the supernatant fluids from BCG-positive leucocyte cultures stimulated with PPD showed a correlation between histamine-release enhancing activity and interferon. Treatment of the culture fluids at pH 2.0 abolished the anti-viral activity, indicating that the interferon was of the type II or 'immune' class. The same treatment only partly abolished the histamine-release enhancing activity. It is concluded that immune-specific stimulation of leucocytes results in the release of soluble mediators that are capable of enhancing IgE-mediated histamine release.
Similar articles
-
Dissociation of IgE from receptors on human basophils. I. Enhanced passive sensitization for histamine release.J Immunol. 1983 Oct;131(4):1949-53. J Immunol. 1983. PMID: 6194222
-
Interferon-induced enhancement of IgE-mediated histamine release from human basophils requires RNA synthesis.J Immunol. 1979 Apr;122(4):1601-3. J Immunol. 1979. PMID: 87438
-
Augmentation of antigen-stimulated histamine release from human basophils by serum-treated zymosan particles. II. Dependence on IgE-mediated release.J Immunol. 1979 Oct;123(4):1468-72. J Immunol. 1979. PMID: 90083
-
Leucocyte mediator release by anti-IgE.Monogr Allergy. 1989;26:103-13. Monogr Allergy. 1989. PMID: 2475769 Review. No abstract available.
-
IgE-dependent histamine-releasing factors.Springer Semin Immunopathol. 1993;15(1):89-98. doi: 10.1007/BF00204628. Springer Semin Immunopathol. 1993. PMID: 7689761 Review. No abstract available.
Cited by
-
Enhancement of basophil chemotaxis in vitro by virus-induced interferon.J Clin Invest. 1981 Feb;67(2):547-52. doi: 10.1172/JCI110065. J Clin Invest. 1981. PMID: 6161946 Free PMC article.
-
Histamine-releasing factors and heterogeneity of IgE.Springer Semin Immunopathol. 1990;12(4):415-28. doi: 10.1007/BF00225327. Springer Semin Immunopathol. 1990. PMID: 1710830 Review.
-
Basophils in human disease.Clin Rev Allergy. 1983 Sep;1(3):427-48. doi: 10.1007/BF02991231. Clin Rev Allergy. 1983. PMID: 6370410 Review.
-
Interleukin 3 activates human blood basophils via high-affinity binding sites.Proc Natl Acad Sci U S A. 1989 Jul;86(14):5542-6. doi: 10.1073/pnas.86.14.5542. Proc Natl Acad Sci U S A. 1989. PMID: 2473472 Free PMC article.
-
Interleukin 3-dependent mediator release in basophils triggered by C5a.J Exp Med. 1989 Aug 1;170(2):467-79. doi: 10.1084/jem.170.2.467. J Exp Med. 1989. PMID: 2474054 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources